The goal of this proposed training program in Viral diseases, Vaccines, and Biodefense (WB) is to provide high quality training to outstanding applicants who will pursue investigative careers in these critical areas. The WB Program will be unique and demanding. It is designed to integrate training in viral diseases and vaccines, with particular concern for their relationship to biodefense. The Program will educate students in both virology and immunology and will bring basic and clinical scientists closer together to facilitate the conduct of translational research. The current training program has a long tradition of postdoctoral education in infectious diseases and immunology, primarily for individuals with MD degrees. The newly designed WB Program will take advantage of continuing strengths in viral diseases and vaccines, coupled with the recent and dramatic expansion in vaccine immunobiology research at Rochester to add a pre-doctoral component to the Program and more PhD recipients to its postdoctoral fellowship program. The pre-doctoral component will build upon a highly successful graduate program in the Department of Microbiology and Immunology, and will utilize the resources of a well-established, interdepartmental graduate training environment. In addition to course work required by the Virology or Immunology Tracks within the Department, WB students will be required to take the reciprocal basic course work in immunology or virology. Postdoctoral fellows will be required to have similar training; all VVB trainees will also take a course in basic epidemiology. Twenty two primary trainers will have principal responsibility for the bulk of the training, and have broad expertise in a variety of areas relevant to the VVB Program, including molecular biology of viruses, viral pathogenesis, clinical trials including evaluation of new vaccines, viral agents of bioterrorism, vaccine development, evolution of immunity, autoimmunity, B-cell biology, T-cell biology, and assay development for assessment of cellular immune responses. Sixteen resource faculty add expertise in epidemiology, biostatistics, access to patient populations for clinical studies, pharmacokinetics, animal models, and microbial pathogenesis. The integrity of the WB Program will be maintained by the WB Meeting, a weekly exercise with mandatory attendance that will include trainee presentations, a journal club, and an outside speakers program. The VVB Meeting will bring together all program faculty and trainees on a regular and frequent basis and will provide a forum for exposure to new ideas and the development of new collaborations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007169-24
Application #
7115798
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Garges, Susan
Project Start
1979-07-01
Project End
2008-08-31
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
24
Fiscal Year
2006
Total Cost
$381,587
Indirect Cost
Name
University of Rochester
Department
Internal Medicine/Medicine
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Chapman, Timothy J; Lambert, Kris; Topham, David J (2011) Rapid reactivation of extralymphoid CD4 T cells during secondary infection. PLoS One 6:e20493
Chapman, Timothy J; Topham, David J (2010) Identification of a unique population of tissue-memory CD4+ T cells in the airways after influenza infection that is dependent on the integrin VLA-1. J Immunol 184:3841-9
Giannandrea, Matthew; Pierce, Robert H; Crispe, Ian Nicholas (2009) Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice. Hepatology 49:2010-20
Sanchez-Lockhart, Mariano; Graf, Beth; Miller, Jim (2008) Signals and sequences that control CD28 localization to the central region of the immunological synapse. J Immunol 181:7639-48
Malboeuf, Christine M; Simon, David A L; Lee, Young-Eun Ellen et al. (2007) Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo. Vaccine 25:3270-6
Divekar, Anagha A; Zaiss, Dietmar M W; Lee, F Eun-Hyung et al. (2006) Protein vaccines induce uncommitted IL-2-secreting human and mouse CD4 T cells, whereas infections induce more IFN-gamma-secreting cells. J Immunol 176:1465-73
Ryan, Elizabeth P; Malboeuf, Christine M; Bernard, Matthew et al. (2006) Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles. J Immunol 177:7811-9
Chapman, Timothy J; Castrucci, Maria R; Padrick, Ryan C et al. (2005) Antigen-specific and non-specific CD4+ T cell recruitment and proliferation during influenza infection. Virology 340:296-306
Sanchez-Lockhart, Mariano; Marin, Elides; Graf, Beth et al. (2004) Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J Immunol 173:7120-4
Tu, Z; Anders, M W (1998) Expression and characterization of human glutamate-cysteine ligase. Arch Biochem Biophys 354:247-54

Showing the most recent 10 out of 20 publications